A new animal model for primary and persistent Epstein-Barr virus infection: Human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis

Journal of Medical Virology

Volumn 80, Issue 3, 2008, Pages 455-466

  Takashima, Kazuaki ^a,b   Ohashi, Makoto ^a   Kitamura, Yukisato ^a   Ando, Kensuke ^a   Nagashima, Kensuke ^a   Sugihara, Hirotsugu ^a   Okuno, Keisuke ^a   Sairenji, Takeshi ^a   Hayashi, Kazuhiko ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b Animal Clinical Research Foundation   (Japan)

Author keywords

Animal model; CT scan; EB virus; Primary infection; Ultrasonography

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 2; IMMEDIATE EARLY PROTEIN BZLF1; LATENT MEMBRANE PROTEIN 1; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CLONAL VARIATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; INFECTIOUS MONONUCLEOSIS; INOCULATION; LATENT VIRUS INFECTION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIMATE; PROTEIN EXPRESSION; RABBIT; SPLENECTOMY; SPLENOMEGALY; T LYMPHOCYTE; VIRUS DETECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL LINE; DISEASE MODELS, ANIMAL; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LIVER; LYMPHOCYTES; MALE; RABBITS; RNA, VIRAL; SPLENOMEGALY;

ANIMALIA; HUMAN HERPESVIRUS 4; ORYCTOLAGUS CUNICULUS; PRIMATES;

EID: 38849173143     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21102     Document Type: Article

References (34)

1. Ambinder RF, Mann RB. 1994. Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 145:239-252.
2. Aozasa K. 1996. Pyothorax-associated lymphoma. Int J Hematol 65:9-16.
3. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, et al. 1984. DNA sequence and expression of the B 95-8Epstein-Barr virus genome. Nature 310:207-211.
4. Catalina MD, Sullivan JL, Bak KR, Luzuriaga K. 2001. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection. J Immunol 167:4450-4457.
5. Chang KL, Chen YY, Shibata D, Weiss LM. 1992. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1:246-255.
6. Chen HL, Hayashi K, Koirala TR, Ino H, Fujimoto K, Yoshikawa Y, Choudhury CR, Akagi T. 1997. Malignant lymphoma induction in rabbits by oral inoculation of crude virus fraction prepared from Ts-B6 cells (cynomolgus B-lymphoblastoid cells harboring Epstein-Barr virus-related simian herpesvirus). Acta Med Okayama 51:141-147.
7. Cohen J. 2005. Clinical aspects of Epstein-Barr virus infection. In: Robertson E, editor. England: Caister Academic Press. pp 35-54.
8. Epstein MA, Achong BG, Barr YM. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 15:702-703.
9. Hanto DW, Sakamoto K, Purtilo DT, Simmons RL, Najarian JS. 1981. The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery 90:204-213.
10. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T. 1990. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128-130.
11. Hayashi K, Chen HL, Yanai H, Koirala TR, Ohara N, Teramoto N, Oka T, Yoshino T, Takahashi K, Miyamoto K, Fujimoto K, Yoshikawa Y, Akagi T. 1999. Cyno-EBV (EBV-related herpesvirus from cynomolgus macaques) induces rabbit malignant lymphomas and their tumor cell lines frequently show specific chromosomal abnormalities. Lab Invest 79:823-835.
12. Hayashi K, Ohara N, Teramoto N, Onoda S, Chen HL, Oka T, Kondo E, Yoshino T, Takahashi K, Yates J, Akagi T. 2001. An animal model for human EBV-associated hemophagocytic syndrome: Herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am J Pathol 158:1533-1542.
13. Hayashi K, Teramoto N, Akagi T. 2002. Animal in vivo models of EBV-associated lymphoproliferative diseases: Special references to rabbit models. Histol Histopathol 17:1293-1310.
14. Hayashi K, Jin Z, Onoda S, Joko H, Teramoto N, Ohara N, Oda W, Tanaka T, Liu YX, Koirala TR, Oka T, Kondo E, Yoshino T, Takahashi K, Akagi T. 2003a. Rabbit model for human EBV-associated hemophagocytic syndrome (HPS): Sequential autopsy analysis and characterization of IL-2-dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS. Am J Pathol 162:1721-1736.
15. Hayashi K, Joko H, Koirala TR, Onoda S, Jin ZS, Munemasa M, Ohara N, Oda W, Tanaka T, Oka T, Kondo E, Yoshino T, Takahashi K, Yamada M, Akagi T. 2003b. Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): Effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease. Histol Histopathol 18:1155-1168.
16. Imashuku S. 2002. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44:259-272.
17. Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneko F. 1997. Clinico-pathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol 133:1081-1086.
18. Iwatsuki K, Yamamoto T, Tsuji K, Suzuki D, Fujii K, Matsuura H, Oono T. 2004. A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infections. Acta Med Okayama 58:169-180.
19. Kawa K. 2000. Epstein-Barr virus-associated diseases in humans. Int J Hematol 71.108-117.
20. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, Tawa A, Hirai K. 1989. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84:51-55.
21. Kieff E. 1996. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott-Raven. pp 2343-2396.
22. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. 1999. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37:132-136.
23. Koirala TR, Hayashi K, Chen HL, Ino H, Kariya N, Yanai H, Choudhury CR, Akagi T. 1997. Malignant lymphoma induction of rabbits with oral spray of Epstein-Barr virus-related herpesvirus from Si-IIA cells (HTLV-II-transformed Cynomolgus cell line): A possible animal model for Epstein-Barr virus infection and subsequent virus-related tumors in humans. Pathol Int 47:442-448.
24. Magana M, Sangueza P, Gil-Beristain J, Sanchez-Sosa S, Salgado A, Ramon G, Sangueza OP. 1998. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): A distinctive type of cutaneous T-cell lymphoma. J Am Acad Dermatol 38:574-579.
25. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV. 2006. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12:1316-1322.
26. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259.
27. Niedobitek G, Agathanggelou A, Finerty S, Tierney R, Watkins P, Jones EL, Morgan A, Young LS, Rooney N. 1994. Latent Epstein-Barr virus infection in cottontop tamarins. A possible model for Epstein-Barr virus infection in humans. Am J Pathol 145:969-978.
28. Okano M, Gross TG. 1996. Epstein-Barr virus-associated hemophagocytic Syndrome and fatal infectious mononucleosis. Am J Hematol 53:111-115.
29. Rickinson A. 2001. Epstein-Barr virus. In: Knipe D, Howley P, editors. Philadelphia: Lippincott Williams & Wilkins. pp 2575-2627.
30. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. 1992. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66:122-131.
31. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM. 1991. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469-474.
32. Su IJ, Wang CH, Cheng AL, Chen RL. 1995. Hemophagocytic syndrome in Epstein-Barr virus-associated T-lymphoproliferative disorders: Disease spectrum, pathogenesis, and management. Leuk Lymphoma 19:401-406.
33. Weiss LM, Chang KL. 1996. Epstein-Barr virus in tumours. Histopathology 29:297-315.
34. Weiss LM, Movahed LA, Warnke RA, Sklar J. 1989. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320:502-506.